Silverback Therapeutics, Inc.
Formulations of Benzazepine Conjugates and Uses Thereof

Last updated:

Abstract:

Aqueous formulations comprising conjugates that comprise a compound comprising benzazepine or a benzazepine-like structure conjugated to a polypeptide are provided, as well as methods of treatment using the aqueous formulations. Lyophilized compositions comprising the conjugates that comprise a compound comprising benzazepine or a benzazepine-like structure conjugated to a polypeptide are also provided.

Status:
Application
Type:

Utility

Filling date:

14 Aug 2020

Issue date:

18 Mar 2021